Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Virtual Pharma - the radical route to success
2.
Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)
3.
The Global Vaccines Market 2008-2023
4.
Global Biotech Market Analysis and Forecasts, 2008-2023
5.
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies Markets, Companies and Opportunities
6.
Picture Archiving and Communications Systems (PACS)
7.
Microarray Markets
8.
Medical Nanotechnology Markets
9.
Contract Manufacturing Opportunities in High-Growth Medical Devices (Catheters, Pacemakers, LVADs, Hip and Knee Implants, Air Pathways, Syringes)
10.
Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps)
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
3.
Peripheral Neuropathy and Neuropathic Pain, 2008
4.
Blood Glucose Testing and Diabetes Management Report
5.
The Global Antibacterials Market R&D Pipelines Market Analysis and Competitive Landscape
6.
Contract Research Annual Review 2008
7.
Good Manufacturing Practice (GMP) Course
8.
Good Clinical Practice I (GCP) course
Generic Series An Introduction to the Canadian Generics Market Key trends and leading companies shaping the market
The Canadian pharmaceutical market is the 8th largest globally and as such represents an important market for generics manufacturers. Although historically dominated by domestic generics companies, mergers and acquisitions over the last five years have increased the dominance of foreign players.
Scope of this report
Overview of the size of the Canadian generics market
Assessment of the key drivers and resistors affecting the Canadian generics market
Profiles of the leading companies in the Canadian generics market
Research and analysis highlights
The Canadian generics sector has recorded steady growth over recent years to become one of the more mature generics markets compared to the other major pharmaceutical markets. However a number of issues impacting the market make it a very different operating environment compared to the neighboring US market.
Domestic generics manufacturers have historically had an advantage in this market however overseas players have increased there presence through acquisitions over recent years to enable them to benefit from the same advantages.
Key reasons to read this report
Assess the size of the Canadian generics market relative to the other major markets globally
Examine the growth drivers and resistors that are shaping this significant generics market
Benchmark the key companies operating in the Canadian generics market
Published: 6 June 2007
PDF Format
Table of Contents
Price: $3,800.00 / GBP2,090.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.